Tenet Healthcare (NYSE:THC) Director Sells 1,152 Shares of Stock

Tenet Healthcare Corporation (NYSE:THC) Director Nadja West sold 1,152 shares of the firm’s stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $258.80, for a total value of $298,137.60. Following the transaction, the director directly owned 23,653 shares of the company’s stock, valued at $6,121,396.40. The trade was a 4.64% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Tenet Healthcare Stock Up 2.0%

Shares of THC traded up $5.11 during mid-day trading on Thursday, reaching $263.64. 870,331 shares of the stock traded hands, compared to its average volume of 742,344. The firm has a market cap of $21.23 billion, a price-to-earnings ratio of 10.17, a P/E/G ratio of 0.99 and a beta of 1.23. Tenet Healthcare Corporation has a 12-month low of $157.58 and a 12-month high of $283.05. The stock has a fifty day simple moving average of $236.52 and a 200 day simple moving average of $210.85. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The business had revenue of $6.04 billion during the quarter, compared to analyst estimates of $5.43 billion. During the same period in the prior year, the company posted $4.02 EPS. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Sell-side analysts expect that Tenet Healthcare Corporation will post 21.04 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the stock. Mizuho set a $290.00 price objective on shares of Tenet Healthcare in a report on Monday, August 10th. Truist Financial boosted their price target on Tenet Healthcare from $270.00 to $290.00 and gave the company a “buy” rating in a research note on Tuesday, July 28th. Guggenheim lifted their price objective on Tenet Healthcare from $242.00 to $283.00 and gave the company a “buy” rating in a report on Tuesday, July 28th. Raymond James Financial reiterated an “outperform” rating and set a $285.00 target price on shares of Tenet Healthcare in a research report on Friday, August 14th. Finally, Weiss Ratings raised shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, August 20th. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, Tenet Healthcare currently has a consensus rating of “Buy” and an average target price of $273.00.

Institutional Investors Weigh In On Tenet Healthcare

A number of hedge funds have recently added to or reduced their stakes in the stock. California State Teachers Retirement System boosted its position in Tenet Healthcare by 18,362.2% in the 2nd quarter. California State Teachers Retirement System now owns 18,885,726 shares of the company’s stock valued at $3,533,142,000 after buying an additional 18,783,432 shares during the last quarter. Norges Bank bought a new position in shares of Tenet Healthcare in the fourth quarter valued at about $248,494,000. Wellington Management Group LLP increased its stake in shares of Tenet Healthcare by 1,114.2% during the fourth quarter. Wellington Management Group LLP now owns 1,135,801 shares of the company’s stock worth $225,706,000 after purchasing an additional 1,042,260 shares during the period. Manning & Napier Advisors LLC acquired a new position in Tenet Healthcare in the 2nd quarter valued at $168,761,000. Finally, Boston Partners raised its position in shares of Tenet Healthcare by 38.8% in the third quarter. Boston Partners now owns 3,147,555 shares of the company’s stock valued at $638,958,000 after buying an additional 880,413 shares in the last quarter. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.